Med Worm: Keyword Buprenorphine

Subscribe to Med Worm: Keyword Buprenorphine feed
MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Suboxone
Updated: 12 min 45 sec ago

Study finds opportunity to increase opioid dependence treatment in Ontario jails

February 14, 2018 - 11:00pm
(McMaster University) The study included completion of an online survey by 27 physicians, who reported working in 15 of 26 provincial correctional facilities for adults in Ontario. This included 10 of the 13 facilities with a population of more than 200. The study identified that about half of the physicians prescribed methadone and half prescribed buprenorphine/naloxone to treat opioid dependence. (Source: EurekAlert! - Social and Behavioral Science)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

New opioid treatment center opens in Dayton region

February 8, 2018 - 11:37am
A new treatment center meant to help individuals with opioid-use disorders has opened in Montgomery County. Dayton Treatment Services, located at 7301 Poe Ave. in Vandalia, is a for-profit organization that offers outpatient, evidence-based treatment interventions for those struggling with opioid addiction. Recognized by the state of Ohio as a licensed narcotics treatment program (NTP), the center offe rs medically assisted treatment that utilizes either Methadone or Suboxone. Future programming… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Telemedicine for Addiction Treatment? Telemedicine for Addiction Treatment?

December 15, 2017 - 2:13pm
One Indiana addiction specialist doesn ’ t shy away from telemedicine, but he still requires in-person visits to begin and maintain his patients ’ Suboxone prescriptions.Kaiser Health News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

FDA Approves Monthly Injection for Opioid Addiction Treatment

December 1, 2017 - 10:08am
WASHINGTON (AP) — U.S. health officials on Thursday approved the first injectable form of the leading medication to treat patients recovering from addiction to heroin, prescription painkillers and other opioids. The Food and Drug Administration approved once-a-month Sublocade for adults with opioid use disorder who are already stabilized on addiction medication. The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthly dose. The older version of the drug, Suboxone, costs $100 a month The approval comes amid the deadliest drug epidemic in U.S. history and a longstanding gap in medication-b...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Orexo nabs regulatory win for fast-dissolving opioid dependence therapy

November 20, 2017 - 9:09am
Orexo (STO:ORX) said today that the European Medicines Agency granted marketing authorization for its Zubsolv rapidly-disintegrating treatment for opioid dependence. The buprenorphine and naloxone sublingual tablet is the first to be approved in Europe with six different strengths, according to the Sweden-based company. Get the full story at our sister site, Drug Delivery Business News. The post Orexo nabs regulatory win for fast-dissolving opioid dependence therapy appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Long- and Short-Acting Opioid Addiction Meds Equally Effective Long- and Short-Acting Opioid Addiction Meds Equally Effective

November 16, 2017 - 10:12am
Extended-release naltrexone and buprenorphine/naloxone are similarly efficacious in preventing relapse for patients with opioid use disorder, although naltrexone was more difficult to initiate.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Opioid Addiction Treatments Face Off in US Trial

November 15, 2017 - 10:47am
CHICAGO (AP) — The first U.S. study to compare two treatments for opioid addiction finds a monthly shot works as well as a daily drug to prevent relapse. The shot requires days of detox first and that proved to be a stumbling block for many. For those who made it past that hurdle, the shot Vivitrol worked about the same as an older treatment, Suboxone. Both drugs had high relapse rates and there were overdoses, including fatal ones, in the experiment in 570 adults. The study , published Tuesday in the journal Lancet, is the first to compare the two drugs in the United States, where an opioid addiction epidemic has doctors and policymakers deeply divided over treatment strategies. Many addiction treatment programs don't offer either medication, or only one of them. "Let's not keep ar...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Study: Head-to-head comparison of opioid use disorder therapies finds similarities

November 15, 2017 - 8:14am
A study published today in The Lancet found that two different therapies used to treat opioid use disorder – an extended-release naltrexone injection and a combination of buprenorphine and naloxone – have similar outcomes once patients get past the hurdle of starting treatment. This is the first study to compare the combination therapy and naltrexone head-to-head in the U.S. The study enrolled 570 opioid-dependent adults, 82% of which were using heroin and 16% of which were abusing pain medications. Get the full story at our sister site, Drug Delivery Business News. The post Study: Head-to-head comparison of opioid use disorder therapies finds similarities appeared first on MassDevice. (Source: Mass Device)

Opioid treatment drugs have similar outcomes once patients initiate treatment

November 14, 2017 - 12:19pm
NIDA study compares buprenorphine/naloxone combination to extended release naltrexone. (Source: National Institutes of Health (NIH) News Releases)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.